New book highlights how small biotech companies are outperforming big pharma
Biotech firms have developed nearly 40 percent more of key treatments for unmet medical needs, says a new book co-authored by Cambridge researchers.
Feb 15, 2022
0
3
Biotech firms have developed nearly 40 percent more of key treatments for unmet medical needs, says a new book co-authored by Cambridge researchers.
Feb 15, 2022
0
3
A reconfigurable "body-on-a-chip" model could transform drug development by simultaneously measuring compound efficacy and toxicity, for both target cells and other organs, such as the heart and liver. These findings, published ...
Jun 19, 2019
0
22
An analysis of patented university inventions licensed to biotechnology firms has revealed early bottlenecks on the path to commercialization. To open these roadblocks, the researchers suggest that better communication of ...
Aug 20, 2014
0
0
A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in marijuana, additional medicines derived from or inspired by the cannabis plant ...
Jan 23, 2012
0
0